Abstract
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) remodel the pericellular environment by regulating the cleavage of extracellular matrix proteins, cell surface components, neurotransmitter receptors, and growth factors that mediate cell adhesion, synaptogenesis, synaptic plasticity, and long-term potentiation. Interestingly, increased MMP activity and dysregulation of the balance between MMPs and TIMPs have also been implicated in various pathologic conditions. In this paper, we discuss various animal models that suggest that the activation of the gelatinases MMP-2 and MMP-9 is involved in pathogenesis of drug dependence, Alzheimer's disease, and epilepsy.
Funding Information
  • Japan Society for the Promotion of Science (21790068, 22390046, 23790082, 23659135)
  • Japan Society for the Promotion of Science (21790068, 22390046, 23790082, 23659135)
  • Japan Society for the Promotion of Science (21790068, 22390046, 23790082, 23659135)
  • Japan Society for the Promotion of Science (21790068, 22390046, 23790082, 23659135)

This publication has 91 references indexed in Scilit: